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This study compares characteristics and place of death of cancer patients receiving specialist 
palliative care in acute hospitals with those who do not.  
 
Methods 
All patients with incident invasive cancer in Ireland (1994-2016 inclusive), excluding non-
melanoma skin cancer, who attended a cancer centre and died in 2016 were identified from 
cancer registry data. Patients were categorised based on a diagnosis code ‘Encounter for 
palliative care’ from linked hospital episode data.  Place of death was categorised from death 
certificate data.  Data were analysed using descriptive statistics, Chi squared tests and logistic 
regression. 
Results 
Of n=4103 decedents identified, 62% had a hospital based palliative care encounter in the 
year preceding death.  Age (p <0.001), marital status (p=0.017), deprivation index (p<0.001) 
and health board region (p=0.008) were independent predictors of having a palliative care 
encounter. Place of death  differed by palliative care  encounter group: 45% of those with an 
encounter died  in  hospital versus 50%  without an encounter, 33% versus 16% died in a 
hospice and  18% versus 28%  died at home (p<0.001).  
Conclusion 
Almost two thirds of cancer patients who attended a cancer centre and died in 2016 had a 
palliative care encounter. They were younger, less likely to be married, and more likely to be 
from deprived areas. Having accounted for sociodemographic factors, there was evidence of 
regional variation in receiving care. Demographic, clinical factors and the provision of health 
services in a region need to be considered together when assessing end of life care. 
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Place of death is an internationally recognised  measure to evaluate end of life care,[1–4]. It is 
affected by patient sociodemographic and clinical factors and characteristics of the health 
service delivering care. An emerging body of evidence shows health service organisation 
must be considered when evaluating patient place of death,[5–10]. 
A systematic review examining factors influencing death at home  in terminally ill cancer 
patients  found three groups of factors important:  those  related to the illness, the individual 
and the environment,[9]. Environmental factors were considered the most important.  A study 
of  over  1.25 million  cancer  deaths in England in 2001-2010 by Gao et al,[7]  found large 
variation in place of death by geographical area of which less than 25% could be explained 
by sociodemographic or clinical characteristics of the patient. A subsequent report proposed a 
population based framework to evaluate the role of different aspects of healthcare services in 
place of death. This  included  health service characteristics such as  service type e.g. adult 
inpatient hospice, hospitals, general practitioner and care homes, and capacity e.g. ratio of 
service facilities to user population, counts of services types within functional areas,[8].  A 
study using the framework  for  all deaths in England in 2014,[6] found almost all health 
service characteristics studied were associated with some of the area-level variation in place 
of death with  service type and capacity were the strongest predictors.  
 
There is a lack of empirical studies examining the delivery of specialist palliative care to 
cancer patients in acute hospitals and whether this impacts place of death. The objectives of 
our study were to i) identify cancer patients who received specialist palliative care in acute 
hospitals in Ireland ii) to compare characteristics of patients receiving specialist palliative 





2.1 Setting   
Ireland has a mixed public private health care system where publically funded health care is 
managed by the Health Service Executive (HSE) and funded through the tax system. All 
residents are entitled to use the public health system. There are eight designated cancer 
centres at publicly-funded hospitals where most cancer surgery takes place.  
 
 The National Clinical Programme for Palliative Care (NCPPC), formed in 2010,   
recommends a ratio of 8 to 10 specialist palliative care beds per 100,000 population,[11]. In  
2015, no community health organisation (CHO) area had the recommended ratio,[12] (table 
1). The NCPPC defines specialist palliative care (level 3 care)  as care provided by health 
care professionals who work solely in palliative care and have extensive knowledge and skills 
in this specialty,[13].  Each of the cancer centres have a specialist palliative care team. In 
2020, there are 10 adult in-patient hospice units providing specialist palliative care in Ireland.  
Neither the former Midlands nor South-Eastern health board region have an inpatient hospice 
(figure 1). Access to hospice is by general practitioner or hospital consultant referral. 
 
 
2.2 Data Sources 
 
The data sources for this study were the National Cancer Registry Ireland (NCRI), the 
Hospital Inpatient Enquiry (HIPE) database from the Health Pricing Office (HPO), and death 
certificate data from the Central Statistics Office (CSO), supplemented by data from the 
Death Events Publication Service (DEPS). We used a collated dataset from the Specialist 
Palliative Care Minimum Data Set (SPC-MDS) for the years 2015-2017 in a validation study 
of HIPE data. SPC-MDS provides data from each acute hospital showing the aggregate 
counts of in-patient new referrals to the specialist palliative care team. Data collection from 
acute hospitals fully commenced in 2016,[12]. 
 
The NCRI records demographic, clinical and treatment information for all cancers diagnosed 
in Ireland, using internationally accepted conventions,[14].  
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HIPE is an electronic based information system that records demographic, clinical and 
administrative data on discharges from all acute public hospitals in Ireland.  Data are 
abstracted from medical records by trained clinical coders and entered into the HIPE system. 
Data quality is critical to the work of HIPE so that  coder training, data quality initiatives and 
the HPO software  ensure that data are being constantly reviewed,[15]. HIPE data captures 
cases that have not had a histological verification of the diagnosis, or for which the registry 
failed to identify a pathology report. For confidentiality reasons, only HIPE episodes that 
mention a cancer diagnosis are available to the registry.  
 
Every death in the Irish State must be recorded and registered within 3 months with the 
General Registers Office. Non-registration is rare because of the necessity of a death 
certificate for many legal purposes,[16]. Cause of death is coded using ICD-10 codes and a 
software system used across Europe to improve international comparability. 
 
The NCRI routinely links HIPE data, DEPS data and death certificate data with registry data 
using probabilistic matching techniques, for case ascertainment and verification purposes. 
Completeness of case ascertainment is estimated to be 98.7%,[17]. The NCRI has permission 
under the Health Act 1997 to collect and hold data on all persons diagnosed with cancer in 
Ireland without requiring individual consent. The use of that data for research is covered by 
the Statutory Instrument which established the Registry Board in 1991. All data were de-
identified prior to analysis. 
 
 
2.3 Data definitions 
 
Demographic information collected by the NCRI at cancer diagnosis include patient name, 
address, gender, date of birth, marital status and smoking status. Clinical information is coded 
using international guidelines including international classification of diseases (ICD) codes, 
[14,18]. For comparison purposes, age categories and tumour grouping  were chosen to match 
those used in the  CSO Vital Statistics Annual Report 2016,[19]. 
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Address  at diagnosis was used to assign a deprivation score using the Pobal HP deprivation 
index,[20]. The index measures the relative affluence or socio-economic disadvantage of a 
geographical area using information collected on education, unemployment and other 
socioeconomic factors from the 2016 Census of Population. Patients are assigned to a health 
board region based on their address at diagnosis. 
 
2.3.1 Indicators for a palliative care encounter 
2.3.1.1 ICD-10-AM Diagnosis code Z51.5 - Encounter for palliative care 
Coding Standards for HIPE (page 36,[18])  state  “Palliative care should be assigned (as an 
additional diagnosis code) when the intent of care at admission is 'for palliation', or if at any 
time during the admission the intent of care becomes 'for palliation', and the care provided to 
the patient meets the definition above.” Palliative care is to be coded when there is 
documentation that the patient has been seen by the palliative care team.  
 
2.3.1.2 Discharge Code - transfer to hospice 
The HIPE discharge code describes the patient destination on discharge. Categories include 
home, nursing home, transfer to another hospital, transfer to hospice and died.  
 
2.4 Study participants 
 
The study population included patients with incident invasive cancer (ICD-O C00-C97),[21] 
excluding non-melanoma skin cancer, diagnosed from 1994-2016 inclusive, who attended 
one of  eight adult cancer centres in 2016 and died in 2016. The study population was 
restricted to patients who attended a designated cancer centre in 2016 because i) cancer 
centres meet required standards so that all the patients have had access to similar standards of 
care including specialist palliative care, ii) acute public hospitals began providing numbers of 
patients referred for specialist palliative care to the national SPC-MDS in 2016 and these 
numbers were used in a validation study and iii) specialist palliative care bed capacity is 
quantified by CHO regions which were established in 2015. 
 




Patients were categorised to two groups: Encounter for palliative care (yes, no) based on 
having at least one indicator for palliative care   in their HIPE data for any acute public 
hospital in the year period preceding death (figure 2). 
2.6 Main outcome measure 
 
Place of death was derived from DEPS data using place of death address. These were 
categorised to Home, Hospital, Hospice and Community care setting.  Community care 
included nursing homes and other long-term residential care settings.  
2.7 Statistical Methods and Analysis 
 
2.7.1 Validation study for encounter for palliative care 
The number of cancer patients who had at least one indicator of palliative care recorded in 
their 2016 HIPE hospital data was counted for each of the eight adult cancer centres. This 
was compared to an aggregate count of new specialist palliative care referrals for cancer 
patients in the SPC-MDS in 2016 by hospital.   
2.7.2 Comparison of study participants with all cancer deaths in 2016 
The demographic and clinical characteristics of the decedents in our study were compared to 
all  2016 cancer deaths  using data from the CSO  Vital Statistics Annual Report 2016,[19]. 
2.7.3 Comparison of characteristics and place of death by encounter for palliative care  
Descriptive statistics are provided for categorical demographic and clinical variables for each 
group: encounter for palliative care (yes, no). Chi squared tests examined the association 
between categorical variables. Logistic regression analysis examined the association of 
sociodemographic factors and former health board region with palliative care encounter 
group. Age, gender, marital status, smoking status, deprivation index, former health board 
region, and age at death were included in the model. Odds ratios (OR) and 95% confidence 
intervals (95% CI) are reported. Tumour groups were excluded from the model because of 
specialisation at certain cancer centres, so that tumour group is related to geographic region. 
Model goodness-of-fit was assessed using Hosmer and Lemeshow test,[22]. Place of death 
was examined by palliative care encounter group. Analyses were carried out using the R 






3.1 Identifying those with an encounter for specialist palliative care  
 
In a validation study, n=3455 patients were identified as having a palliative care encounter 
from HIPE data compared to n=3688 patients from the SPC minimum dataset. This 
represents a 6% difference. Four of the eight cancer centres closely matched the SPC-MDS 
aggregate counts with greater variation in the other four.   
For the main analysis, n=4126 decedents were identified (figure 2), representing 45% of all 
reported deaths in Ireland from malignant neoplasm  in 2016 (n=9171),[19]. They were 
younger and a higher proportion (39% versus 33%) were from the former Eastern health 
board region (table 2). Decedents were broadly similar in terms of cancer diagnosis apart 
from cancers of the digestive organs (C15-C18) and blood cancers (C81-C96); 26% of study 
decedents versus 31% of all cancer decedents had cancer of the digestive organs while 11% 
of study decedents versus 8% of all cancer decedents had a blood cancer (table 2).  In total 
85% of the decedents in our study were diagnosed in the five year period 2012-2016. 
 
3.2 Comparison by palliative care encounter group 
Of the n=4126 decedents identified we excluded a further n=23 patients whose palliative care 
encounter occurred more than one year before death. Of the remaining n=4103 decedents, 
62% had a palliative care encounter in the year preceding death and 38% did not (table 3). 
Age and deprivation showed the strongest association with a palliative care encounter (table 
3).  Overall median survival was 309 days (IQR 97-906 days). The palliative care encounter 
group had a shorter median survival of 296 days (IQR 93-850 days) versus 323 days (IQR 
108-1012 days) in the no encounter group.  Median time from the admission date of the last 
‘encounter for palliative care’ episode to death was 28 days (IQR 13-53 days).  
Of those with a Z51.5 code, 82% occurred at a cancer centre and 18% occurred in other acute 
hospitals. 
The North Western region had the highest proportion (73%) of decedents in receipt of a 
palliative care encounter while the Midlands region had the lowest (57%)  (table 4). 
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3.2.1 Logistic regression analysis 
 
Decedents who were not married had increased odds of having a palliative care encounter 
(OR 1.22, 95% CI 1.07-1.39). Using the least deprived quintile as a reference, those in the 
most deprived quintile had increased odds of an encounter (OR 1.59, 95% CI 1.25-2.03) 
(table 5). Relative to those under 65 years of age  odds of a palliative care encounter 
decreased as age increased from  0.78 (95% CI 0.66-0.92) in  the  65-74 year  age-group to  
0.59 (95% CI 0.47-0.74) in  the 85 years and over age-group. Accounting for 
sociodemographic factors, decedents in the Midlands and South East were significantly less 
likely to have a palliative care encounter relative to those in the Eastern health board region. 
 
3.3 Place of death 
 
Hospital was the most common place of death (47%) followed by hospice (27%) and home 
(22%) (table 6). Place of death  differed between the palliative care  encounter groups, 45% 
versus 50%  died  in  hospital, 33% versus 16% died in a hospice and  18% versus 28%  died 




Almost two thirds of cancer patients who attended an adult cancer centre in 2016 and died in 
2016 had a palliative care encounter. They were younger, less likely to be married, and more 
likely to be from deprived areas than those who didn’t. Proportions having palliative care 
varied by health board region. Hospital was the most common place of death across the 
groups, but those having a palliative care encounter were proportionately twice as likely to 
die in hospice. 
 
4.1 Strengths and weaknesses 
This study uses high quality population based cancer registry data, linked to hospital episode 
data and death certificate data and is population based, however there are some limitations. 
Variables from the cancer registry dataset including marital status and smoking status are 
collected once at diagnosis. The majority (85%) of our study participants were diagnosed 




Address  at diagnosis was used to assign a deprivation score using the Pobal HP deprivation 
index,[20], however  23% of 2016 decedents  are classified as having an unknown 
deprivation score. This usually arises because the patient address cannot be resolved to a 
single geographic area.  
 
Our study dataset represents 45% of all malignant cancer deaths reported in Ireland in 2016. 
Although broadly similar in characteristics, the decedents in our study were younger relative 
to the total population of 2016 cancer decedents. A smaller proportion (5%) had a cancer of 
the digestive organs and a higher proportion (3%) had a blood cancer diagnosis.  It has been 
reported that patients treated at cancer centres are younger than those treated in other public 
hospitals. Differences in referral patterns has been cited as one explanation for this, for 
example patients considered better candidates for treatment,[24]. The majority of decedents 
in our study were diagnosed in the 5 year period 2012-2016, 50% died within one year and 
75% within three years of diagnosis which indicates our study population are representative 
of recently diagnosed cancer patients in the active phase of treatment.  
 
Using HIPE to identify those having a palliative care encounter may underestimate the actual 
numbers seen.  A single centre study in New York examined the validity of the ICD-9 code 
V66.7 (Encounter for palliative care) from hospital episode data,[25]. The code had high 
specificity (99.1%) and low sensitivity (49.9%); sensitivity was higher in patients with non-
metastatic cancer (61.9%), and metastatic cancer (66.3%). The authors concluded studies 
using this code would identify patients who have a high likelihood of having received care, 
but will not capture all patients who receive palliative care. We also cannot be certain a Z51.5 
diagnostic code guarantees a patient received specialist palliative care i.e. care provided by 
health care professionals who work solely in palliative care. To mitigate this, we restricted 
our study population to decedents who attended one of eight cancer centres in 2016, each of 
which have specialised cancer services and specialist palliative care teams. We included 
discharge to a hospice as an indicator for palliative care given the likely need for a 
consultation with the palliative care team before discharging to this setting. Lastly we 
undertook a validation study where HIPE patient-level counts at four of eight cancer centres 
closely matched the SPC-MDS aggregate counts with greater variation in the other four. For 
the SPC-MDS, the treating clinician decides which disease is prompting the referral to end of 
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life care whereas the NCRI uses international guidelines to determine cancer[14]. The SPC-
MDS counts are new referrals only while this distinction is not available from HIPE.  
 
4.2 Comparison with other studies 
 
4.21 Palliative care encounter and age 
There was a trend of decreasing odds for a palliative care encounter with increasing age. This 
is consistent with results from a previous retrospective  study of  patients with advanced 
cancer at a single medical centre in Houston, Texas,[26]. Access to palliative care for older 
adults is a recognised problem,[27,28]. Reasons cited include  attitudinal differences to the 
care of older people, a focus on curative treatments within hospitals and a lack of 
resources,[27]. A qualitative study of older patients (aged 70 or older) reported that older 
patients may have  less clear early signs indicating that they need palliative care and are  not 
referred,[28].  The authors noted the lack of a clear diagnosis of dying may explain why the 
palliative care needs of older patients in particular are not recognised. The patients in our 
study represent cancer patients in the active phase of treatment so further investigation of 
why the older decedents within this population were less like to receive a palliative care 
encounter is warranted.  Calls to more  fully characterise cancer patients treated outside these 
centres have also been made,[24]. Our study can provide a baseline for comparisons, 
particularly for palliative care. 
 
4.22 Palliative care encounter and marital status  
We found patients who were not married were more likely to have a palliative care encounter. 
This  differs from the results of a 2012 study that found married patients were more likely to 
have a palliative care consultation,[26].  Demographic information including marital status 
was retrieved was from the medical charts for these patients. It is not clear if this happened at 
the date of diagnosis of cancer or advanced cancer for the n=816 patients in the study. That 
study like ours may suffer from misclassification bias. 
 
4.23 Palliative care and smoking status 
A perceived and implicit bias against patients with smoking-related lung disease has been 
reported as a potential barrier to palliative care,[29]. Smoking status was unknown for 38% of 
our study population so we could not reliably examine the association between smoking 
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status and receipt of palliative care in cancer patients, 22% of whom had cancer of the 
respiratory and intrathoracic organs. Removing smoking status from the logistic regression 
model did not change the results. 
 
 
4.24 Palliative care encounter and deprivation 
Although more than a quarter of the decedents in our study have unknown deprivation 
category, there is a clear positive association of a palliative care encounter with increasing 
deprivation.  In England inpatient hospice death is more likely among decedents living in less 
deprived areas than among those living in more deprived areas,[30]. A broader review  
suggested use of specialist palliative care in cancer patients may modify the effect of 
socioeconomic status on place of death,[31]. Our study supports this, however access to 
specialist palliative care itself may be driven by socioeconomic factors. 
 
 
4.25 Palliative care encounter and regional variation 
Having accounted for sociodemographic factors, decedents in the South Eastern and 
Midlands regions had a statistically significant decreased odds of a palliative care encounter 
relative to the Eastern region. Regional-level variation in specialist palliative care services in 
Ireland is  well documented,[32,33]. Neither the South Eastern nor Midlands regions have an 
inpatient hospice and limited inpatient specialist palliative care beds which may explain why 
decedents from these regions have reduced access to specialist palliative care.  
 
4.26 Palliative care encounter and place of death  
Hospital was the most common place of death for all the decedents in our study which  is 
broadly consistent with previous studies,[6,7,34,35]. Interestingly, this was true for the group 
who had a palliative care encounter, although the proportions dying in hospital (45% versus 
50%) and at home (18% versus 28%) were lower.  This may be due to limited inpatient 
hospice care facilities and specialist palliative care beds which is a known problem in 
Ireland[11]. Studies to investigate differences in end of life care between the two groups 





Access to specialist palliative care affects subsequent place of death. Demographic, clinical 
factors and the provision of health services in a region affect access to specialist palliative 
care in acute hospitals and need to be considered together when assessing end of life care. 
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Table 1. Estimation of Specialist palliative care bed (SPC) capacity by health board region 




* Source:  http://hospicefoundation.ie/wp-content/uploads/2018/01/National-Survey-of-Patient-Activity.pdf. 
Table 3, page 12. (Weafer JA, Toft S. National summary of patient activity data for adult specialist palliative 
care services in the Republic of Ireland, 2012-2015) 
† See supplementary data file, figures 1 and 2 for additional information.  
‡All the specialist palliative care beds are in the two hospices located in the former North Western health board 
region. 
Former health 
board region  
CHO 
area 
CHO   




Former health board region geographical 
overlap with CHO† 
Estimated  
health board  
SPC 
capacity  
North Western 1 4.1 Contained completely within CHO 1 High‡ 
 
North Eastern 1 4.1 Split between CHO 1 and CHO 8 - 
North Eastern 8 0.0 Split between  CHO 1 and CHO 8 - 
Midlands  8 0.0 Contained completely within CHO 8 Low 
Western 2 4.0 Same region - 
Mid-Western 3 7.9 Same region High 
Southern 4 6.6 Same region  
South Eastern 5 0.4 Same region Low 
Eastern 6 3.3 Split  between  CHO 6, CH0 7 and CHO 9  - 
Eastern 7 6.5 Split  between  CHO 6, CH0 7 and CHO 9 - 
Eastern 9 7.4 Split  between  CHO 6, CH0 7 and CHO 9 - 
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Table 2. Comparison of clinical and demographic characteristics of all deaths from malignant 
neoplasm in 2016 with the study dataset.  
*Source: https://www.cso.ie/en/releasesandpublications/ep/pvsar/vitalstatisticsannualreport2016/deaths2016/  
(Central Statistics Office. Deaths 2016 - CSO - Central Statistics Office. Vital Statistics Annual Report 2016. 
2019.) 








Attended a cancer 
centre in  2016 and 




Gender   
Female 4370 (48 ) 1867 (45 ) 
Male 4801 (52 ) 2259 (55 ) 
Age at death   
0–14 18 (0 ) <10 (0 ) 
15–24 15 (0 ) <10 (0 ) 
25–34 68 (1 ) 42 (1 ) 
35–44 169 (2 ) 111 (3 ) 
45–54 566 (6 ) 323 (8 ) 
55–64 1369 (15 ) 747 (18 ) 
65–74 2512 (27 ) 1255 (30 ) 
75–84 2839 (31 ) 1195 (29 ) 
85 & over 1615 (18 ) 442 (11 ) 
   
Cancer type†    
C00–C14  (Lip, oral cavity and pharynx) 188 (2 ) 146 (3 ) 
C15–C26  (Digestive organs) 2856 (31 ) 1221 (26 ) 
C30–C39  (Respiratory and intrathoracic organs) 1985 (22 ) 1033 (22 ) 
C40–C41  (Bone and articular cartilage) 31 (0 ) 11 (0 ) 
C43–C44  (Skin) 263 (3 ) 117 (2 ) 
C45–C49 (Mesothelial and soft tissue) 122 (1 ) 58 (1 ) 
C50  (Breast) 763 (8 ) 405 (9 ) 
C51–C58  (Female genital organs) 537 (6 ) 267 (6 ) 
C60–C63  (Male genital organs) 531 (6 ) 341 (7 ) 
C64–C68  (Urinary tract) 458 (5 ) 269 (6 ) 
C69–C72  (Eye, brain and other parts of central nervous system) 344 (4 ) 178 (4 ) 
C73–C75  (Thyroid and other endocrine glands) 46 (1 ) 26 (1 ) 
C76–C80  (Ill–defined ( secondary and unspecified sites) 316 (3 ) 136 (3 ) 
C81–C96 (Lymphoid, haematopoietic and related tissue) 731 (8 ) 545 (11 ) 
Former health board region   
Eastern  3038 (33 ) 1620 (39 ) 
North East 819 (9 ) 265 (6 ) 
South East 1060 (12 ) 471 (11 ) 
West 892 (10 ) 509 (12 ) 
Midlands 522 (6 ) 123 (3 ) 
North West 586 (6 ) 148 (4 ) 
South 1419 (15 ) 608 (15 ) 
Mid West 835 (9 ) 382 (9 ) 
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Table 3. Patient demographic and clinical variables by palliative care group. 
 
†Based on n= 4727 tumours. 
 No encounter 














Chi squared test 
of association 
Smoker Status      
Ever 587 (38) 1100 (43) 1687 (41) 
p <0.001 
 
Never 319 (21) 548 (21) 867 (21) 
Unknown 639 (41) 910 (36) 1549 (38) 
Marital Status      
Married 876 (57) 1354 (53) 2230 (54) 
p =0.017 Other 669 (43) 1204 (47) 1873 (46) 
Gender      
Female 667 (43) 1186 (46) 1853 (45) 
p =0.046 Male 878 (57) 1372 (54) 2250 (55) 
Deprivation      
1 Least 234 (15) 306 (12) 540 (13) 
p <0.001 
 
2 208 (13) 302 (12) 510 (12) 
3 221 (14) 370 (14) 591 (14) 
4 195 (13) 373 (15) 568 (14) 
5 Most 242 (16) 513 (20) 755 (18) 
Unknown 445 (29) 694 (27) 1139 (28) 
Age at death      
<65 years 382 (25) 843 (33) 1225 (30) 
p <0.001 
 
65–74 465 (30) 783 (31) 1248 (30) 
75–84 502 (32) 688 (27) 1190 (29) 
85 & over 196 (13) 244 (10) 440 (11) 
Tumour count per patient     
1  tumour 1306 (85) 2223 (87) 3529 (86) 
p =0.034 
 
>  1  tumour 239 (15) 335 (13) 574 (14) 
Tumour group†    
C00–C14  (Lip, oral cavity and pharynx) 46 (3) 100 (3) 146 (3) 
p <0.001 
 
C15–C26  (Digestive organs) 458 (25) 759 (26) 1217 (26) 
C30–C39  (Respiratory and intrathoracic organs) 357 (20) 668 (23) 1025 (22) 
C40–C41  (Bone and articular cartilage) <10 (0) <10 (0) 11 (0) 
C43–C44  (Skin) 47 (3) 70 (2) 117 (2) 
C45–C49 (Mesothelial and soft tissue) 17 (1) 41 (1) 58 (1) 
C50  (Breast) 157 (9) 241 (8) 398 (8) 
C51–C58  (Female genital organs) 74 (4) 192 (7) 266 (6) 
C60–C63  (Male genital organs) 157 (9) 183 (6) 340 (7) 
C64–C68  (Urinary tract) 100 (6) 168 (6) 268 (6) 
C69–C72  (Eye, brain and other parts of central 
nervous system) 63 (3) 114 (4) 177 (4) 
C73–C75  (Thyroid and other endocrine glands) 10 (1) 16 (1) 26 (1) 
C76–C80  (Ill–defined ( secondary and unspecified 
sites) 64 (4) 72 (2) 136 (3) 
C81–C96 (Lymphoid, haematopoietic and related 


















































































243   
(41 ) 






























Table 5. Odds ratios† and 95% confidence intervals for a palliative care encounter by 









Variable  Odds ratio(95% CI) 
Smoker status  
Ever 1.0 
Never 0.97 (0.81, 1.15) 
Unknown 0.77 (0.66, 0.89) 
Marital status  
Married 1.0 
Other 1.22 (1.07, 1.39) 
Gender  
Female   1.0 
Male 0.9 (0.79, 1.02) 
Deprivation  
1 Least   1.0 
2 1.1 (0.85, 1.41) 
3 1.3 (1.01, 1.66) 
4 1.46 (1.13, 1.89) 
5 Most  1.59 (1.25, 2.03) 
Unknown 1.26 (1.01, 1.56) 
Age category  
< 65 years 1.0 
65-74 years 0.78 (0.66 , 0.92) 
75-84 years 0.63 (0.53, 0.75) 
85 years and over 0.59 (0.47, 0.74) 
Former health board region  
Eastern  1.0 
North East 1.15 (0.87, 1.54) 
South East 0.77 (0.62, 0.97) 
West 1.12 (0.90, 1.39) 
Midlands 0.66 (0.4 , 0.97) 
North West 1.38 (0.94 , 2.05) 
South 0.82 (0.67, 1.0) 












Place of death 
No encounter 














Chi squared test 
of association 
Hospital 768  (50 ) 1159  (45 ) 1927  (47 ) 
p < 0.001 
 
Hospice 253  (16 ) 839  (33 ) 1092  (27 ) 
Home 434  (28 ) 472  (18 ) 906  (22 ) 
Community care setting 90  (6 ) 88  (3 ) 178  (4 ) 
23 
 
Figure 1. Former health board regions in Ireland with inpatient hospice location indicated by 
black dots. 
















































All incident invasive cancers (ICD-O3, C00-C97), 
excluding non-melanoma skin cancers, diagnosed 
from 1994-2016 inclusive.  
Patients with at least one episode in one of the 8 
cancer centres in 2016.  
n= 24909 
 n 
Died in 2016 
n= 4137 
Encounter for palliative care, 
n=2597 
Patients with at least one diagnostic 
code of ‘Z51.5 - encounter for 
palliative care’ or a ‘discharge to 
hospice’ recorded in their episode 
data for any HIPE hospital in 2015-
2016, inclusive  
(2114 decedents were ‘Z51.5’ only, 71 
hospice only and 412 both) 
 
No encounter for palliative care, 
n=1540 
Patients with no record of a ‘Z51.5 - 
encounter for palliative care’ 
diagnostic code or ‘discharge to 
hospice’ recorded in their episode 
data for any HIPE hospital in 2015-
2016, inclusive  
 






Figure 3, Odds ratios† and 95% confidence intervals for a palliative care encounter by 





†Reference: smoker-‘ever smoker’,  marital status-‘Married’, gender ‘Female’, deprivation-






Figure 4, Place of death by former health board region for decedents with an encounter for 
palliative care in an acute hospital. 
 
 
 
 
